These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7547360)

  • 21. Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice.
    Boelen A; Andeweg A; Kwakkel J; Lokhorst W; Bestebroer T; Dormans J; Kimman T
    Vaccine; 2000 Nov; 19(7-8):982-91. PubMed ID: 11115725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine.
    Kakuk TJ; Soike K; Brideau RJ; Zaya RM; Cole SL; Zhang JY; Roberts ED; Wells PA; Wathen MW
    J Infect Dis; 1993 Mar; 167(3):553-61. PubMed ID: 8440926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
    Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
    J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant measles virus incorporating heterologous viral membrane proteins for use as vaccines.
    Swett-Tapia C; Bogaert L; de Jong P; van Hoek V; Schouten T; Damen I; Spek D; Wanningen P; Radošević K; Widjojoatmodjo MN; Zahn R; Custers J; Roy S
    J Gen Virol; 2016 Sep; 97(9):2117-2128. PubMed ID: 27311834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.
    Murphy BR; Collins PL
    J Clin Invest; 2002 Jul; 110(1):21-7. PubMed ID: 12093883
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
    Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
    Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with an adjuvanted low-energy electron irradiation inactivated respiratory syncytial virus vaccine shows immunoprotective activity in mice.
    Bayer L; Fertey J; Ulbert S; Grunwald T
    Vaccine; 2018 Mar; 36(12):1561-1569. PubMed ID: 29439869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner?
    Hussell T; Openshaw P
    Curr Opin Microbiol; 1999 Aug; 2(4):410-4. PubMed ID: 10458984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current progress on development of respiratory syncytial virus vaccine.
    Chang J
    BMB Rep; 2011 Apr; 44(4):232-7. PubMed ID: 21524347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccines for neonatal viral infections: towards a live respiratory syncytial virus vaccine:a study in risk.
    McIntosh ED; Malinoski FJ; Randolph VB
    Expert Rev Vaccines; 2004 Aug; 3(4):353-7. PubMed ID: 15270633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.
    Hwang HS; Lee YT; Kim KH; Ko EJ; Lee Y; Kwon YM; Kang SM
    Virology; 2017 Nov; 511():142-151. PubMed ID: 28846899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New vaccines against mucosal pathogens: rotavirus and respiratory syncytial virus.
    Coffin SE; Offit PA
    Adv Pediatr Infect Dis; 1997; 13():333-48. PubMed ID: 9544318
    [No Abstract]   [Full Text] [Related]  

  • 33. Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.
    O'Konek JJ; Makidon PE; Landers JJ; Cao Z; Malinczak CA; Pannu J; Sun J; Bitko V; Ciotti S; Hamouda T; Wojcinski ZW; Lukacs NW; Fattom A; Baker JR
    Hum Vaccin Immunother; 2015; 11(12):2904-12. PubMed ID: 26307915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus.
    Fleeton MN; Chen M; Berglund P; Rhodes G; Parker SE; Murphy M; Atkins GJ; Liljeström P
    J Infect Dis; 2001 May; 183(9):1395-8. PubMed ID: 11294672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine.
    Prince GA; Curtis SJ; Yim KC; Porter DD
    J Gen Virol; 2001 Dec; 82(Pt 12):2881-2888. PubMed ID: 11714962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.
    Karron RA; Wright PF; Belshe RB; Thumar B; Casey R; Newman F; Polack FP; Randolph VB; Deatly A; Hackell J; Gruber W; Murphy BR; Collins PL
    J Infect Dis; 2005 Apr; 191(7):1093-104. PubMed ID: 15747245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease.
    Prince GA; Denamur F; Deschamps M; Garçon N; Prieels JP; Slaoui M; Thiriart C; Porter DD
    Vaccine; 2001 Feb; 19(15-16):2048-54. PubMed ID: 11228376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine.
    Trudel M; Nadon F; Séguin C; Brault S; Lusignan Y; Lemieux S
    Vaccine; 1992; 10(2):107-12. PubMed ID: 1539463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A recombinant subunit vaccine for bovine RSV and Histophilus somni protects calves against dual pathogen challenge.
    Gershwin LJ; Behrens NE; McEligot HA; Carvallo-Chaigneau FR; Crum LT; Gunnarson BM; Corbeil LB
    Vaccine; 2017 Apr; 35(15):1954-1963. PubMed ID: 28274639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV.
    Peebles RS; Sheller JR; Collins RD; Jarzecka K; Mitchell DB; Graham BS
    J Infect Dis; 2000 Sep; 182(3):671-7. PubMed ID: 10950758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.